{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:04:29Z","timestamp":1773353069767,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11894-008-0021-z","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T16:15:52Z","timestamp":1205770552000},"page":"54-59","source":"Crossref","is-referenced-by-count":14,"title":["High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis"],"prefix":"10.1007","volume":"9","author":[{"given":"Timothy","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex S.","family":"Befeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"R.H. Wiesner","year":"1989","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, et al.: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K. Burak","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, et al.: Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004, 99:523\u2013526.","journal-title":"Am J Gastroenterol"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","volume":"332","author":"Y. Lee","year":"1995","unstructured":"Lee Y, Kaplan MM: Primary sclerosing cholangitis. N Engl J Med 1995, 332:924\u2013933.","journal-title":"N Engl J Med"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","volume":"106","author":"K.D. Lindor","year":"1994","unstructured":"Lindor KD, Dickson ER, Baldus WP, et al.: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994, 106:1284\u20131290.","journal-title":"Gastroenterology"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","volume":"110","author":"K.D. Lindor","year":"1996","unstructured":"Lindor KD, Therneau TM, Jorgensen RA, et al.: Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996, 110:1515\u20131518.","journal-title":"Gastroenterology"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"R.E. Poupon","year":"1997","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, et al.: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997, 113:884\u2013890.","journal-title":"Gastroenterology"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","volume":"29","author":"P. Angulo","year":"1999","unstructured":"Angulo P, Batts KP, Therneau TM, et al.: Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999, 29:644\u2013647.","journal-title":"Hepatology"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","volume":"30","author":"P. Angulo","year":"1999","unstructured":"Angulo P, Dickson ER, Jorgensen RA, et al.: Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999, 30:830\u2013835.","journal-title":"J Hepatol"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","volume":"23","author":"C. Colombo","year":"1996","unstructured":"Colombo C, Battezzati, Podda M, et al.: Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. Hepatology 1996, 23:1484\u20131490.","journal-title":"Hepatology"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.510260102","volume":"26","author":"A. Benedetti","year":"1997","unstructured":"Benedetti A, Alvaro D, Bassotti C, et al.: Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductile fragments and isolated perfused rat liver. Hepatology 1997, 26:9\u201321.","journal-title":"Hepatology"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.1840120523","volume":"12","author":"D.L. Schmucker","year":"1990","unstructured":"Schmucker DL, Ohta M, Kanai S, et al.: Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990, 12:1216\u20131221.","journal-title":"Hepatology"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840120307","volume":"12","author":"P.R. Galle","year":"1990","unstructured":"Galle PR, Theilmann L, Raedsch R, et al.: Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990, 12:486\u2013491.","journal-title":"Hepatology"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","volume":"30","author":"A.K. Batta","year":"1989","unstructured":"Batta AK, Arora R, Salen G, et al.: Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. J Lipid Res 1989, 30:1953\u20131962.","journal-title":"J Lipid Res"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","volume":"15","author":"C. Colombo","year":"1992","unstructured":"Colombo C, Castellani MR, Balistreri WF, et al.: Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 1992, 15:677\u2013684.","journal-title":"Hepatology"},{"key":"21_CR15","first-page":"893","volume":"90","author":"A.W.M. Milligen De Wit van","year":"1995","unstructured":"van Milligen De Wit AWM, van Deventer SJH, Tytgat GNJ: Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am J Gastroenterol 1995, 90:893\u2013900.","journal-title":"Am J Gastroenterol"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","volume":"16","author":"M. Yoshikawa","year":"1992","unstructured":"Yoshikawa M, Tsujii T, Matsumura K, et al.: Immuno-modulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992, 16:358\u2013364.","journal-title":"Hepatology"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0016-5085(94)90127-9","volume":"107","author":"S. Hillaire","year":"1994","unstructured":"Hillaire S, Boucher E, Calmus Y, et al.: Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 1994, 107:781\u2013788.","journal-title":"Gastroenterology"},{"key":"21_CR18","first-page":"455","volume":"106","author":"D.H. Thiel Van","year":"1994","unstructured":"Van Thiel DH, Caroll P, Abu-Elmagd K, et al.: Tacrolimus (FK506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1994, 106:455\u2013459.","journal-title":"Am J Gastroenterol"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2004.02214.x","volume":"20","author":"R.K. Sterling","year":"2004","unstructured":"Sterling RK, Salvatori JJ, Luketic VA, et al.: A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. Aliment Pharmacol Ther 2004, 20:943\u2013949.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","volume":"106","author":"T.A. Knox","year":"1994","unstructured":"Knox TA, Kaplan MM: A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994, 106:494\u2013499.","journal-title":"Gastroenterology"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-200012000-00005","volume":"31","author":"A. Duchini","year":"2000","unstructured":"Duchini A, Younossi ZM, Saven A, et al.: An open-label pilot trial of cladibrine (2-cholorodeoxyadenosine) in patients with primary sclerosing cholangitis. J Clin Gastroenterol 2000, 31:292\u2013296.","journal-title":"J Clin Gastroenterol"},{"key":"21_CR22","first-page":"449","volume":"41","author":"K. Kyokane","year":"1994","unstructured":"Kyokane K, Ichihara T, Horisawa M, et al.: Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid. Hepatogastroenterology 1994, 41:449\u2013452.","journal-title":"Hepatogastroenterology"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","volume":"95","author":"H.J.F. Hoogstraten van","year":"2000","unstructured":"van Hoogstraten HJF, Vleggaar FP, Boland GJ, et al.: Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Am J Gastroenterol 2000, 95:2015\u20132022.","journal-title":"Am J Gastroenterol"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","volume":"95","author":"P. Angulo","year":"2000","unstructured":"Angulo P, Batts KP, Jorgensen RA, et al.: Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000, 95:2333\u20132337.","journal-title":"Am J Gastroenterol"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:DDAS.0000011827.87103.2e","volume":"49","author":"M.P. Epstein","year":"2004","unstructured":"Epstein MP, Kaplan MM: A pilot study of etanercept in the treatment of primary sclerosing cholangitis. Dig Dis Sci 2004, 49:1\u20134.","journal-title":"Dig Dis Sci"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","volume":"95","author":"A.E. Bharucha","year":"2000","unstructured":"Bharucha AE, Jorgensen R, Lichtman SN, et al.: A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000, 95:2338\u20132342.","journal-title":"Am J Gastroenterol"},{"key":"21_CR27","first-page":"57","volume":"85","author":"K.D. Lindor","year":"1991","unstructured":"Lindor KD, Wiesner RH, Colwell LJ, et al.: The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991, 85:57\u201361.","journal-title":"Am J Gastroenterol"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","volume":"108","author":"R.F. Olsson","year":"1995","unstructured":"Olsson RF, Broome U, Danielsson A, et al.: Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995, 108:1199\u20131203.","journal-title":"Gastroenterology"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0016-5085(88)90180-1","volume":"95","author":"N.F. LaRusso","year":"1988","unstructured":"LaRusso NF, Wiesner RH, Ludwig J, et al.: Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988, 95:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"21_CR30","first-page":"1204A","volume":"114","author":"P. Angulo","year":"1998","unstructured":"Angulo P, Bharucha AE, Jorgensen RA, et al.: Oral nicotine in the treatment of primary sclerosing cholangitis: a pilot study. Gastroenterology 1998, 114:1204A.","journal-title":"Gastroenterology"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00042737-200102000-00013","volume":"13","author":"F.P. Vleggaar","year":"2001","unstructured":"Vleggaar FP, van Buuren HR, van Berge Henegouwen GP, et al.: No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study. Eur J Gastroenterol Hepatol 2001, 13:171\u2013175.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","volume":"40","author":"M. Farkkila","year":"2004","unstructured":"Farkkila M, Karvonen A, Nurmi H, et al.: Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 2004, 40:1379\u20131386.","journal-title":"Hepatology"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","volume":"14","author":"C.B. O\u2019Brien","year":"1991","unstructured":"O\u2019Brien CB, Senior JR, Arora-Mirchandani R, et al.: Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991, 14:838\u2013847.","journal-title":"Hepatology"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","volume":"16","author":"U. Beuers","year":"1992","unstructured":"Beuers U, Spengler U, Kruis W, et al.: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992, 16:707\u2013714.","journal-title":"Hepatology"},{"key":"21_CR35","first-page":"92A","volume":"16","author":"S.K. Lo","year":"1992","unstructured":"Lo SK, Hermann R, Chapman RW, et al.: Ursodeoxycholic acid in primary sclerosing cholangitis: a double-blind placebo controlled trial. Hepatology 1992, 16:92A.","journal-title":"Hepatology"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","volume":"20","author":"A. Stiehl","year":"1994","unstructured":"Stiehl A, Walker S, Stiehl L, et al.: Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis: a 3-year pilot study with a placebo-controlled study period. J Hepatol 1994, 20:57\u201364.","journal-title":"J Hepatol"},{"key":"21_CR37","first-page":"1472","volume":"43","author":"N. Maria De","year":"1996","unstructured":"De Maria N, Colantoni A, Rosenbloom E, et al.: Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period. Hepatogastroenterology 1996, 43:1472\u20131479.","journal-title":"Hepatogastroenterology"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"K.D. Lindor","year":"1997","unstructured":"Lindor KD: Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997, 336:691\u2013695.","journal-title":"N Engl J Med"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80059-7","volume":"29","author":"H.J.F. Hoogstraten van","year":"1998","unstructured":"van Hoogstraten HJF, Wolfhagen FHJ, van de Meeberg PC, et al.: Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. J Hepatol 1998, 29:417\u2013423.","journal-title":"J Hepatol"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1590-8658(03)00076-8","volume":"35","author":"L. Okolicsanyi","year":"2003","unstructured":"Okolicsanyi L, Groppo M, Floreani A, et al.: Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of retrospective Italian multicentre survey. Dig Liver Dis 2003, 35:325\u2013331.","journal-title":"Dig Liver Dis"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1111\/j.1572-0241.1999.01543.x","volume":"94","author":"P. Angulo","year":"1999","unstructured":"Angulo P, Larson DR, Therneau TM, et al.: Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:3310\u20133313.","journal-title":"Am J Gastroenterol"},{"key":"21_CR42","first-page":"1146A","volume":"110","author":"D. Bansi","year":"1996","unstructured":"Bansi D, Christie J, Fleming K, et al.: High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind, placebo-controlled trial. Gastroenterology 1996, 110:1146A.","journal-title":"Gastroenterology"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","volume":"96","author":"D.M. Harnois","year":"2001","unstructured":"Harnois DM, Angulo P, Jorgensen RA, et al.: High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1558\u20131562.","journal-title":"Am J Gastroenterol"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"S.A. Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi DS, Hunt N, et al.: A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001, 121:900\u2013907.","journal-title":"Gastroenterology"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R. Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, Schaffalitsky de Muckadell O, et al.: High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005, 129:1464\u20131472.","journal-title":"Gastroenterology"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"B.Y. Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, et al.: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001, 134:89\u201395.","journal-title":"Ann Intern Med"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(87)90766-5","volume":"2","author":"M.J. Hill","year":"1987","unstructured":"Hill MJ, Melville DM, Lennard-Jones JE, et al.: Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987, 2:185\u2013186.","journal-title":"Lancet"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","volume":"124","author":"D.S. Pardi","year":"2003","unstructured":"Pardi DS, Loftus EV, Kremers WK, et al.: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889\u2013893.","journal-title":"Gastroenterology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0021-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-008-0021-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0021-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T01:07:14Z","timestamp":1630890434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-008-0021-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0021-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}